why choose us

First received: April 26, 2023

Clinical Trial: Pharmacokinetics, Pharmacodynamics and Safety of Epeleuton in Patients With Sickle Cell Disease

Study Status: Completed

Recruit Status: RECRUITING

Condition: Sickle Cell Disease

Study Type: INTERVENTIONAL


Official Title: An Open-label Mechanistic Study to Assess the Pharmacokinetics, Pharmacodynamics and Safety of Orally Administered Epeleuton in Patients With Sickle Cell Disease

Brief Summary: To assess the pharmacokinetics, pharmacodynamics and safety of Epeleuton capsules in adult SCD patients who are aged ?18 years.

Read more